Consistently, the results of the present study demonstrated that CM from THP-1 cells pretreated with reLBP (resulting in increased TGF-β1 levels) significantly enhanced the migration and invasion capabilities of GC cells through the upregulation of p-Smad3. This evidence concerns the gene SMAD3 and gastric cancer.